Back
HNR Acquisition Vs. Corcept Therapeutics Industry Stock Comparison
Sell
1
HNRA
HNR Acquisition
Last Price:
1.21
Seasonality Move:
-41.53%
Buy
68
CORT
Corcept Therapeutics
Last Price:
40.92
Seasonality Move:
-0.77%
Sell
1
HNR Acquisition (HNRA)
is a Sell
Is HNR Acquisition a Buy, Sell or Hold?
- The current HNR Acquisition [HNRA] share price is $1.07. The Score for HNRA is 1, which is 98% below its historic median score of 50, and infers higher risk than normal.
- HNRA is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Buy
68
Corcept Therapeutics (CORT)
is a Buy
Is Corcept Therapeutics a Buy, Sell or Hold?
- The current Corcept Therapeutics [CORT] share price is $42.27. The Score for CORT is 68, which is 36% above its historic median score of 50, and infers lower risk than normal.
- CORT is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
HNRA Stock Price Chart
What is HNR Acquisition's stock price today?
-
The HNR Acquisition share price today is $1.07
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HNRA is experiencing selling pressure, which indicates risk of future bearish movement.
CORT Stock Price Chart
What is Corcept Therapeutics's stock price today?
-
The Corcept Therapeutics share price today is $42.27
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CORT is experiencing slight buying pressure.
HNRA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.32 | Sell |
| Relative Strength Index (14 RSI): | 28.51 | Sell |
| Chaikin Money Flow: | -169933 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.24 - 2.16) | Sell |
| Bollinger Bands (100): | (1.78 - 2.62) | Sell |
CORT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.36 | Buy |
| Relative Strength Index (14 RSI): | 82.3 | Buy |
| Chaikin Money Flow: | 670376 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (33.47 - 37.45) | Buy |
| Bollinger Bands (100): | (28.16 - 35.86) | Buy |
HNRA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.17 | Sell |
| 20-day SMA: | 1.58 | Sell |
| 50-day SMA: | 2.12 | Sell |
| 200-day SMA: | 2.22 | Sell |
| 8-day EMA: | 1.21 | Sell |
| 20-day EMA: | 1.51 | Sell |
| 50-day EMA: | 1.91 | Sell |
| 200-day EMA: | 3.21 | Sell |
CORT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 37.44 | Buy |
| 20-day SMA: | 35.75 | Buy |
| 50-day SMA: | 34.88 | Buy |
| 200-day SMA: | 28.43 | Buy |
| 8-day EMA: | 38.24 | Buy |
| 20-day EMA: | 36.43 | Buy |
| 50-day EMA: | 34.68 | Buy |
| 200-day EMA: | 30.05 | Buy |
HNR Acquisition Earnings Growth & HNRA Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, an increase next quarter of $0.37 per share, a decrease this year of $0.00 per share, and an increase next year of $1.46 per share.
Corcept Therapeutics Earnings Growth & CORT Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.06 per share, an increase next quarter of $0.15 per share, an increase this year of $0.22 per share, and an increase next year of $0.59 per share.
HNR Acquisition Technical Analysis
| Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Corcept Therapeutics Technical Analysis
| Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||